- Report
- February 2026
- 381 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
The Neurological Dysfunction market is a subset of the larger Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This market includes a range of products and services, such as drugs, medical devices, diagnostics, and services, that are used to treat neurological disorders. These products and services are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke.
The Neurological Dysfunction market is highly competitive, with a number of companies offering products and services to treat neurological disorders. Some of these companies include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more